Shipment impairs lymphocyte proliferative responses to microbial antigens

Clin Diagn Lab Immunol. 2000 Sep;7(5):759-63. doi: 10.1128/cdli.7.5.759-763.2000.

Abstract

Lymphocyte proliferation assays (LPAs) are widely used to assess T-lymphocyte function of patients with human immunodeficiency virus infection and other primary and secondary immunodeficiency disorders. Since these assays require expertise not readily available at all clinical sites, specimens may be shipped to central labs for testing. We conducted a large multicenter study to evaluate the effects of shipping on assay performance and found significant loss of LPA activity. This may lead to erroneous results for individual subjects and introduce bias into multicenter trials.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Candida / immunology
  • Cell Division
  • HIV Infections / blood
  • HIV Infections / immunology*
  • Humans
  • Lymphocytes / cytology
  • Lymphocytes / immunology*
  • Pokeweed Mitogens / immunology
  • Specimen Handling / adverse effects*
  • Specimen Handling / methods
  • Streptokinase / immunology
  • Tetanus Toxoid / immunology
  • Transportation

Substances

  • Pokeweed Mitogens
  • Tetanus Toxoid
  • Streptokinase